Drug

Fentanyl Citrate Pectin-Based Nasal Spray clinical trials

A product of Fentanyl; its studies count on that page too.

studies test it: 3
open now: 0
in phase 3: 0
first study started: 2013

How each study uses Fentanyl Citrate Pectin-Based Nasal Spray is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States: 30 Jun 2011 · LAZANDA · NDA 022569 (FDA, Drugs@FDA)
European Union: 24 Jan 2006 · Ionsys · EMEA/H/C/000612 (EMA; as Fentanyl; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lazanda: 3
Fentanyl: 2

Studies by the year they started

3 studies that test it; most in 2013 (1)

Studies that test Fentanyl Citrate Pectin-Based Nasal Spray, by start year
Year	Studies
2013	1
2015	1
2017	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 1
Phase 4: 1

Who runs them

Industry 0 · Other 3

Richard C Reznichek, MD (1) · Defense and Veterans Center for Integrative Pain Management (1) · Joseph Ma (1)

Related medicines

As reviewed, each with the page that says it.

A dosage form of Fentanyl source

Studies

Open first, then newest update. How each study uses Fentanyl Citrate Pectin-Based Nasal Spray is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.